Department of Cardiac Surgery Research, Inova Heart and Vascular Institute, Inova Fairfax Hospital, 3300 Gallows Rd, Suite 109 B, Falls Church, VA 22042, USA.
J Thorac Cardiovasc Surg. 2010 Mar;139(3):686-91. doi: 10.1016/j.jtcvs.2009.10.010. Epub 2009 Dec 11.
Chronic lung disease is a significant comorbidity in patients undergoing cardiac surgery. Chronic lung disease is currently being classified and reported to the Society of Thoracic Surgeons database by using either clinical interview or spirometric testing. We sought to compare the chronic lung disease classification captured by the 2 methods.
We performed a prospectively designed study in which patients presenting for cardiac surgery, excluding emergent patients, were screened for a history of asthma, a history of 10 or more pack-years of smoking, a persistent cough, and the use of oxygen. Each selected patient underwent spirometry. The presence and severity of chronic lung disease was coded per Society of Thoracic Surgeons guidelines by using the 2 methods of clinical report and spirometric results. The chronic lung disease classifications were compared, and differences were determined by using concordance and discordance rates. The results were then used to construct Society of Thoracic Surgeons-predicted risk models.
The discordant rate was 39.1%, with underestimation of the severity of chronic lung disease in 94% of misclassified patients. This affected the Society of Thoracic Surgeons-predicted risk models for prolonged ventilation, morbidity/mortality, and mortality by increasing the predicted risk when spirometry was used for morbidity/mortality by an average of 1.5 +/- 1.2 percentage points (P < .001) and prolonged ventilation time by an average of 1.3 +/- 1.4 percentage points (P < .001).
The use of patient history for symptoms, medication, and/or oxygen use as the only method to determine chronic lung disease for this subgroup of patients led to underreporting of chronic lung disease and underestimation of the risk for adverse outcomes. Therefore data submission to the Society of Thoracic Surgeons database should be designed to capture and correct for potential bias in the definition of chronic lung disease because the rate of spirometry in different centers in defining chronic lung disease is not regulated.
慢性肺部疾病是心脏手术患者的一种严重合并症。目前,慢性肺部疾病是通过临床访谈或肺功能测试来分类并向胸外科医生协会数据库报告的。我们旨在比较这两种方法所捕捉到的慢性肺部疾病分类。
我们进行了一项前瞻性设计的研究,其中筛选了接受心脏手术的患者(不包括急诊患者),以确定他们是否有哮喘病史、是否有 10 年以上的吸烟史、持续性咳嗽以及是否需要吸氧。每个选定的患者都进行了肺功能检查。按照胸外科医生协会的指南,使用临床报告和肺功能结果这两种方法对慢性肺部疾病的存在和严重程度进行编码。比较慢性肺部疾病的分类,并通过一致性和不一致性的比率来确定差异。然后使用这些结果构建胸外科医生协会预测风险模型。
不一致率为 39.1%,在 94%的分类错误的患者中,慢性肺部疾病的严重程度被低估了。这影响了胸外科医生协会预测的风险模型,例如延长通气时间、发病率/死亡率和死亡率,当使用肺功能测试来预测发病率/死亡率时,风险平均增加了 1.5 +/- 1.2 个百分点(P <.001),延长通气时间平均增加了 1.3 +/- 1.4 个百分点(P <.001)。
对于这组患者,仅使用患者的病史、症状、药物使用和/或吸氧情况来确定慢性肺部疾病,会导致慢性肺部疾病的漏报和对不良结果风险的低估。因此,向胸外科医生协会数据库提交数据时,应设计用于捕捉和纠正慢性肺部疾病定义中的潜在偏差,因为不同中心使用肺功能测试来定义慢性肺部疾病的比率没有得到监管。